Concepedia

Marina Kremyanskaya

MK

47

Publications

1.5K

Citations

23

H-Index

2005

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

Mayo Clinic in Arizona

Mays Cancer Center at UT Health San Antonio

Marina Kremyanskaya is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2005–2024

47

Publications

47

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek et al. · Blood · 2019 · 165 citations · Full text

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca et al. · Journal of Clinical Oncology · 2023 · 75 citations · Full text

Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Harry P. Erba, Amir T. Fathi, Ghayas C. Issa et al. · Blood · 2022 · 68 citations

, , +11

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

John Mascarenhas, Raajit K. Rampal, Heidi Kosiorek et al. · Blood Advances · 2020 · 67 citations · Full text

A Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia

Aaron T. Gerds, Alessandro M. Vannucchi, Francesco Passamonti et al. · Blood · 2019 · 66 citations

Rows per page

1–5 of 47